Loading
Latest filing published 14 Jul 2022 for Marrone BIO Innovations INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Keith Pitts (senior executive) discloses dealings in Marrone Bio Innovations Inc to SEC (Form 4). In total, 4 filings cover trades dated from 26 May 2021 to 12 July 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 14 July 2022 came the latest disclosure, a share grant in Marrone Bio Innovations Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations